Prevalence of symptoms, ever having received a diagnosis and treatment of depression and anxiety, and associations with health service use amongst the general population in two Russian cities

• Main Authors: Cook, Sarah, Kudryavtsev, Alexander V., Bobrova, Natalia, Saburova, Lyudmila, Denisova, Diana, Malyutina, Sofia, Lewis, Glyn, Leon, David A.
• Format: Article in Journal/Newspaper
• Language: unknown
• Published: figshare 2020
• Subjects: Medicine; Pharmacology; Biotechnology; Cancer; Science Policy; 111714 Mental Health; FOS Health sciences; Arkhangelsk
• Online Access: https://dx.doi.org/10.6084/m9.figshare.c.5206420; https://springernature.figshare.com/collections/Prevalence_of_symptoms_ever_having_received_a_diagnosis_and_treatment_of_depression_and_anxiety_and_associations_with_health_service_use_amongst_the_general_population_in_two_Russian_cities/5206420

Abstract Background Little is known about the burden of common mental disorders in Russia despite high levels of suicide and alcohol-related mortality. Here we investigated levels of symptoms, self-reports of ever having received a diagnosis and treatment of anxiety and depression in two Russian cities. Methods The study population was men and women aged 35–69 years old participating in cross-sectional population-based studies in the cities of Arkhangelsk and Novosibirsk (2015–18). Participants completed an interview which included the PHQ-9 and GAD-7 scales, questions on whether participants had ever received a diagnosis of depression or anxiety, and health service use in the past year. Participants also reported current medication use and medications were coded in line with the WHO anatomical therapeutic classification (ATC). Depression was defined as PHQ-9 ≥ 10 and Anxiety as GAD-7 ≥ 10. Results Age-standardised prevalence of PHQ-9 ≥ 10 was 10.7% in women and 5.4% in men (GAD-7 ≥ 10 6.2% in women; 3.0% in men). Among those with PHQ-9 ≥ 10 17% reported ever having been diagnosed with depression (equivalent finding for anxiety 29%). Only 1.5% of those with PHQ-9 ≥ 10 reported using anti-depressants and 0.6% of those with GAD-7 ≥ 10 reported using anxiolytics. No men with PHQ-9 ≥ 10 and/or GAD-7 ≥ 10 reported use of anti-depressants or anxiolytics. Use of health services increased with increasing severity of both depression and anxiety. Conclusion There was a large gap between symptoms and reporting of past diagnosis and treatment of common mental disorders in two Russian cities. Interventions aimed at improving mental health literacy and reducing stigma could be of benefit in closing this substantial treatment gap.